Home/Filings/4/0001156039-20-000080
4//SEC Filing

Alter Jeffrey D. 4

Accession 0001156039-20-000080

CIK 0001156039other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:31 PM ET

Size

7.2 KB

Accession

0001156039-20-000080

Insider Transaction Report

Form 4
Period: 2020-10-01
Alter Jeffrey D.
EVP, IngenioRx & Anthem Health
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-10-01+10,65910,659 total
    Exercise: $270.17Exp: 2030-10-01Common Stock (10,659 underlying)
  • Award

    Common Stock

    2020-10-01+2,7462,746 total
Footnotes (2)
  • [F1]Represents restricted share units. Restrictions lapse as follows: 915 shares each on 10/1/2021 and 10/1/2022, and 916 shares on 10/1/2023.
  • [F2]The option represents a right to purchase a total of 10,659 shares, and is exercisable in three annual installments of 3,553 shares each, beginning on 10/1/2021, which is the one-year anniversary of the option grant date.

Issuer

Anthem, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001813868

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:31 PM ET
Size
7.2 KB